吉林做一次包皮切除手术多少钱吉林早泄去什么医院治靠谱,吉林做包皮手术大概多少天能好,吉林那个医院做包皮过长比较好,吉林看早泄得多少钱,吉林的男科医院哪家比较好,吉林男科医院怎么走,吉林早泻的最佳治疗方法

Two hundred million dollars – that's how much money Monat Global says it made selling hair care products in 2017 through multi-level marketing.YouTube videos show the family behind Monat in mansions and driving fancy cars — but an ongoing class action lawsuit claims the company is nothing more than a pyramid scheme.Three recently filed class action lawsuits accuse Monat of fraud and deception."An inherent design and/or manufacturing defect in Monat hair care products causes significant hair loss and scalp irritation to many consumers," one lawsuit alleges."I'm devastated with what my hair looks like right now," said Heather Fox, a Monat customer in Phoenix."I had to cut off my hair," said Monat Market Partner Erin Ostby.Both women say Monat did them more damage than good."My dad used to always say I was like Samson from the Bible – I got my power from my hair. So it was really upsetting and I couldn't do that to someone else," said Ostby, who recently stopped selling Monat.CLICK TO SEE THE ORIGINAL COMPLAINTSThe U.S. Food and Drug Administration has received and is in the process of assessing 187 adverse event reports related to Monat products. The FDA received these reports between  Aug. 2, 2017 8/27/17 and March 9, 2018.More than 500 complaints have been filed with the Better Business Bureau in South Florida, where Monat is headquartered.  "Any reputable lab will tell you there's nothing in the products that would cause this kind of reaction in a large population – there just isn't. You can rub it in your skin, you can drink it if you like, within reason. It's not going to cause this kind of reaction," Monat Spokesperson Gene Grabowski said in a phone interview.But the company's repeated response to BBB complaints states that, "although Monat's ingredients are naturally-based, safe, pure and sustainable, we understand that some may experience a reaction and should discontinue use."The class action lawsuits claim the products use numerous "harsh chemicals" and "known human allergens."  One controversial ingredient the suit highlights is Capixyl – containing red clover – which some say should be on a warning label."Yes, there should be a warning label, but only if the amount was higher," Grabowski said.The University of Maryland Medical Center says women with a history of breast cancer should avoid red clover due to its estrogen-like effects in the body. It also says red clover may interfere with the liver's ability to process some drugs."The amount of red clover used (red clover extract) is so small that it would have no effect," said Grabowski.According to the FDA, cosmetic companies are responsible for ensuring the safety of their own products, which in most cases don't require government approval before they go on the market."We do tests before we send them to market and we know they're safe," said Grabowski. "I mean, those aren't clinical tests."Monat's website shows the clinical tests they did utilized one active ingredient per study.As the class action lawsuits were recently filed, Monat has not yet responded to the claims in court.    3161

Turkey on Wednesday intensified its clash with the United States, announcing heavy new tariffs on some American products including cars, alcohol and tobacco.Turkish Vice President Fuat Oktay said on Twitter that the measures were in response to "the deliberate attack of the US administration on our economy."The Turkish government has doubled its retaliatory tariffs on American cars to 120 percent and on alcoholic drinks to 140 percent, according to a notice published Wednesday. Other affected products include fruit, coal, makeup and rice.Relations between Washington and Ankara have rapidly soured in recent weeks over Turkey's detention of the American pastor Andrew Brunson.The Trump administration announced plans last week to double US tariffs imports of steel and aluminum from Turkey. On Wednesday, a Turkish court rejected a second appeal to release Brunson. 884

UPDATE SATURDAY, JUNE 26 - 7:50 A.M.ESCONDIDO POLICE WATCH COMMANDER TOLD ABC 10NEWS THE MISSING WOMAN WAS FOUND FRIDAY IN ESCONDIDO AND "WAS OK."---SAN DIEGO (KGTV) -- San Diego County sheriff’s officials are asking for the public’s help in finding a woman who disappeared after a trip to Pala Casino.According to sheriff’s officials, someone contacted deputies at the department’s San Marcos station just after 10:30 a.m. Thursday to report Katelyn Schwindt missing.The person who contacted deputies said the 27-year-old Schwindt posted a message on her Facebook page that indicated she was at Pala Casino on the evening of June 24. In the same message, Schwindt wrote that she was possibly drugged and assaulted.ABC 10News spoke with Schwindt's friend, Krystle Hudnell. When Hudnell saw the Facebook posts, she said there were too many typos for it to be a joke.Some parts of it read:"I DONT KNOW WHAT HAS HAPPE D I HAVE BEEN ASSULTED AND I AM LOST AND SCARED…""PLEASEV IM INNEDD OF HELP BAD IM INJURED I THINK IM BEING KID NAPPED…""As soon as I saw her post, it didn't seem like her, and it just seemed really scary," Hudnell said.Officials said deputies and detectives from the San Marcos station investigated but were unable to find her.Schwindt is white, 5 feet 5 inches tall, and has brown hair and brown eyes. It is unknown what kind of clothing she may be wearing.Friends have a mass search party planned at Pala Casino on Sunday.Anyone with information on Schwindt’s whereabouts is urged to contact the sheriff’s department at 760-510-5200. 1559

VACAVILLE, Calif. (AP) — Crews were battling wildfires in the San Francisco Bay Area and thousands of people were under orders to evacuate Wednesday as hundreds of wildfires blazed across the state amid a blistering heat wave now in its second week. Gov. Gavin Newsom blamed the extraordinary weather and thousands of lightning strikes for 367 known fires, including 23 major fires or groups of fires. He said the state has recorded nearly 11,000 lightning strikes in 72 hours. Ash and smoke filled the air over San Francisco, which is surrounded by wildfires burning in multiple counties to the north, east and south. 626

U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to be helping them.Independent monitors had paused enrollment in the study two weeks ago because of a possible safety issue. But on Monday, the National Institute of Allergy and Infectious Diseases, which sponsors the study, said a closer look did not verify a safety problem but found a low chance that the drug would prove helpful for hospitalized patients.It is a setback for one of the most promising treatment approaches for COVID-19. President Donald Trump received a similar experimental, two-antibody drug from Regeneron Pharmaceuticals Inc. on an emergency basis when he was sickened with the coronavirus earlier this month.In a statement Lilly notes that the government is continuing a separate study testing the antibody drug in mild to moderately ill patients, to try to prevent hospitalization and severe illness. The company also is continuing its own studies testing the drug, which is being developed with the Canadian company AbCellera.Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. The experimental drugs are concentrated versions of one or two specific antibodies that worked best against the coronavirus in lab and animal tests.Lilly and Regeneron have asked the U.S. Food and Drug Administration to grant emergency use authorization for their drugs for COVID-19 while late-stage studies continue. Lilly says its request is based on other results suggesting the drug helps patients who are not hospitalized, and that it will continue to seek the FDA’s permission for emergency use.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 1928